• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,886.91 -416.72
( -0.54%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,332.91 11.82
(0.11%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524400
INE806D01016
37.5752508
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.93
23.02
EPS(TTM)
Face Value()
Div & Yield %
2.97
10
0
 

zydus wellness ltd
J&K Bank gains after board clears Rs 1,250-cr fundraising plan
Nov 27,2025
The bank will raise up to Rs 750 crore in one or more tranches through a Qualified Institutional Placement (QIP), subject to shareholder approval and applicable regulatory clearances.

Additionally, the board has approved raising up to Rs 500 crore via non-convertible, redeemable, unsecured, Basel III-compliant Tier II debentures on a private placement basis, pending requisite regulatory approvals.

J&K Bank offers banking services under the three major divisions as support services, depository services, and third-party services.

The bank reported a 1.91% jump in net profit to Rs 494.11 crore on a 2.04% decline in total income to Rs 3,446.71 crore in Q2 FY26 over Q1 FY26. On a year-on-year (YoY) basis, the company’s net profit declined 10.31%, and revenue rose 0.79% in Q2 FY26.